Risdiplam Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 0.75 mg/mL
Reference Brands: Evrysdi (USA/EU)
Category:
Neurology
Risdiplam is an oral survival motor neuron 2 (SMN2) splicing modifier used to treat spinal muscular atrophy (SMA) in adults and children aged 2 months and older. It works by increasing the production of functional SMN protein, essential for maintaining motor neuron function. Risdiplam helps improve muscle strength and slow disease progression in SMA patients.
Risdiplam is available in Oral Solution
and strengths such as 0.75 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Risdiplam is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Risdiplam can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing